Isolated Intraocular Relapse of Pediatric B-cell Precursor Acute Lymphoblastic Leukaemia Following Chimeric Antigen Receptor T-lymphocyte Therapy

B Cell ◽

T Lymphocyte ◽

Chimeric Antigen Receptor ◽

Lymphoblastic Leukaemia ◽

Antigen Receptor ◽

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

The Lancet ◽

10.1016/s0140-6736(20)32334-5 ◽

2020 ◽

Vol 396 (10266) ◽

pp. 1885-1894

Author(s):

Reuben Benjamin ◽

Charlotte Graham ◽

Deborah Yallop ◽

Agnieszka Jozwik ◽

Oana C Mirci-Danicar ◽

...

Keyword(s):

T Cells ◽

B Cell ◽

Chimeric Antigen Receptor ◽

Lymphoblastic Leukaemia ◽

Phase 1 ◽

Antigen Receptor ◽

Two Phase

Faculty Opinions recommendation of Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718430955.793495858 ◽

2014 ◽

Author(s):

Jacob Rowe ◽

Tsila Zuckerman

Keyword(s):

B Cell ◽

Lymphoblastic Leukaemia ◽

Research Council ◽

Medical Research Council ◽

Chromosomal Abnormalities ◽

Randomised Trial ◽

Cell Precursor ◽

Prognostic Effect ◽

The Uk

Long-term follow-up of blinatumomab in patients with relapsed/refractory Philadelphia chromosome–positive B-cell precursor acute lymphoblastic leukaemia: Final analysis of ALCANTARA study

European Journal of Cancer ◽

10.1016/j.ejca.2020.12.022 ◽

2021 ◽

Vol 146 ◽

pp. 107-114

Author(s):

Giovanni Martinelli ◽

Nicolas Boissel ◽

Patrice Chevallier ◽

Oliver Ottmann ◽

Nicola Gökbuget ◽

...

Keyword(s):

B Cell ◽

Lymphoblastic Leukaemia ◽

Philadelphia Chromosome ◽

Final Analysis ◽

Cell Precursor ◽

Long Term Follow Up ◽

Philadelphia Chromosome Positive

CD99 expression is strongly associated with clinical outcome in children with B-cell precursor acute lymphoblastic leukaemia

British Journal of Haematology ◽

10.1111/bjh.15683 ◽

2018 ◽

Vol 184 (3) ◽

pp. 418-423 ◽

Cited By ~ 3

Author(s):

Dongfeng Chen ◽

Alessandro Camponeschi ◽

Qingqing Wu ◽

Natalija Gerasimcik ◽

Huiqi Li ◽

...

Keyword(s):

Clinical Outcome ◽

B Cell ◽

Lymphoblastic Leukaemia ◽

Aneuploidy in children with relapsed B‐cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse

British Journal of Haematology ◽

10.1111/bjh.15770 ◽

2019 ◽

Vol 185 (2) ◽

pp. 266-283 ◽

Cited By ~ 5

Author(s):

Stefanie Groeneveld‐Krentz ◽

Michael P. Schroeder ◽

Michael Reiter ◽

Malwine J. Pogodzinski ◽

Helia J. Pimentel‐Gutiérrez ◽

...

Keyword(s):

B Cell ◽

Lymphoblastic Leukaemia ◽

Clinical Importance ◽

Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial

The Lancet Oncology ◽

10.1016/s1470-2045(10)70066-8 ◽

2010 ◽

Vol 11 (5) ◽

pp. 429-438 ◽

Cited By ~ 227

Author(s):

Anthony V Moorman ◽

Hannah M Ensor ◽

Sue M Richards ◽

Lucy Chilton ◽

Claire Schwab ◽

...

Keyword(s):

B Cell ◽

Lymphoblastic Leukaemia ◽

Research Council ◽

Medical Research Council ◽

Chromosomal Abnormalities ◽

Randomised Trial ◽

Cell Precursor ◽

Prognostic Effect ◽

The Uk

Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study

Medical Oncology ◽

10.1007/s12032-015-0582-2 ◽

2015 ◽

Vol 32 (4) ◽

Author(s):

Emma Bergfelt ◽

Piotr Kozlowski ◽

Lucia Ahlberg ◽

Erik Hulegårdh ◽

Hans Hägglund ◽

...

Keyword(s):

B Cell ◽

Minimal Residual Disease ◽

Lymphoblastic Leukaemia ◽

Older Patients ◽

Residual Disease ◽

Intensive Chemotherapy ◽

Cell Precursor ◽

Satisfactory Outcome ◽

Minimal Residual

Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy

British Journal of Haematology ◽

10.1111/j.1365-2141.2009.08059.x ◽

2010 ◽

Vol 149 (1) ◽

pp. 93-100 ◽

Cited By ~ 14

Author(s):

Herbert Pichler ◽

Anja Möricke ◽

Georg Mann ◽

Andrea Teigler-Schlegel ◽

Felix Niggli ◽

...

Keyword(s):

B Cell ◽

Lymphoblastic Leukaemia ◽

Consolidation Therapy ◽

Cell Precursor ◽

Post Induction ◽

Prognostic Relevance

IKZF1 deletions associate with CRLF2 overexpression leading to a poor prognosis in B-cell precursor acute lymphoblastic leukaemia

Translational Oncology ◽

10.1016/j.tranon.2021.101291 ◽

2022 ◽

Vol 15 (1) ◽

pp. 101291

Author(s):

Ana Luiza Tardem Maciel ◽

Thayana da Conceição Barbosa ◽

Caroline Barbieri Blunck ◽

Karolyne Wolch ◽

Amanda de Albuquerque Lopes Machado ◽

...

Keyword(s):

B Cell ◽

Lymphoblastic Leukaemia ◽

Poor Prognosis ◽

Rational Response-Adapted Risk Stratification and Treatment for Children with Late Bone Marrow Relapses of B-Cell Precursor Acute Lymphoblastic Leukaemia: A Report from the ALL-REZ BFM Trial Group

SSRN Electronic Journal ◽

10.2139/ssrn.3388826 ◽

2019 ◽

Author(s):

Cornelia Eckert ◽

Stefanie Groeneveld-Krentz ◽

Renate Kirschner-Schwabe ◽

Nikola Hagedorn ◽

Christiane Chen-Santel ◽

...

Keyword(s):

Bone Marrow ◽

Risk Stratification ◽

B Cell ◽

Lymphoblastic Leukaemia ◽

Trial Group ◽